Small Heterodimer Partner, an Orphan Nuclear Receptor, Augments Peroxisome Proliferator-activated Receptor γ Transactivation*
暂无分享,去创建一个
M. Matsuda | S. Kihara | T. Funahashi | Y. Matsuzawa | I. Shimomura | H. Kuriyama | D. Moore | K. Hotta | K. Yamagata | K. Kishida | H. Nishizawa | N. Maeda | H. Nishigori | H. Tomura | Tadashi Nakamura | H. Nagaretani | Masahiko Takahashi | J. Takeda
[1] J. Chen,et al. The SRC family of nuclear receptor coactivators. , 2000, Gene.
[2] AC Tose. Cell , 1993, Cell.
[3] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[4] Warszawski Uniwersytet Medyczny,et al. Diabetes care , 2019, Health at a Glance.
[5] M. Ito,et al. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.
[6] J. Auwerx,et al. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[7] Guillaume Adelmant,et al. Activation of PPARγ coactivator-1 through transcription factor docking , 1999 .
[8] D. Moore,et al. Novel receptor interaction and repression domains in the orphan receptor SHP , 1997, Molecular and cellular biology.
[9] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[10] D. Moore,et al. , Margarita for Repression MechanismsReceptor Transactivation : Two XHepatocyte Nuclear Factor 4 and Retinoid The Orphan Nuclear Receptor SHP Inhibits , 1999 .
[11] J. Thomsen,et al. The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ERα and ERβ* , 1999, The Journal of Biological Chemistry.
[12] J. Thomsen,et al. The Orphan Nuclear Receptor SHP Utilizes Conserved LXXLL-Related Motifs for Interactions with Ligand-Activated Estrogen Receptors , 2000, Molecular and Cellular Biology.
[13] B. Spiegelman,et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.
[14] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[15] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[16] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[17] K. Umesono,et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.
[18] Y. Pak,et al. The Orphan Nuclear Receptor Small Heterodimer Partner as a Novel Coregulator of Nuclear Factor-κB in Oxidized Low Density Lipoprotein-treated Macrophage Cell Line RAW 264.7* , 2001, The Journal of Biological Chemistry.
[19] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[20] J. Holder,et al. Repeat Treatment of Obese Mice With BRL 49653, a New Potent Insulin Sensitizer, Enhances Insulin Action in White Adipocytes: Association With Increased Insulin Binding and Cell-Surface GLUT4 as Measured by Photoaffinity Labeling , 1995, Diabetes.
[21] A. Zelent,et al. Origins and evolutionary diversification of the nuclear receptor superfamily , 2000, Cellular and Molecular Life Sciences CMLS.
[22] S. O’Rahilly,et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.
[23] Y. Iwamoto,et al. Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDM , 1991, Diabetes Care.
[24] J. Gustafsson,et al. Cloning and Expression of a Novel Mammalian Thioredoxin* , 1997, The Journal of Biological Chemistry.
[25] A. Monaco,et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.
[26] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[27] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[28] C. Day. Thiazolidinediones: a new class of antidiabetic drugs , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[29] D. Moore,et al. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements , 1994, Molecular and cellular biology.
[30] Y. Matsuzawa,et al. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] Z. Wu,et al. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. , 1998, The Journal of clinical investigation.
[32] T. Fujiwara,et al. Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats , 1988, Diabetes.
[33] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[34] P. Puigserver,et al. A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.
[35] E. Lalli,et al. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis , 1997, Nature.